| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.36 |
4e-16 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
6e-14 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.33 |
9e-14 |
| mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
2e-08 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
6e-08 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-07 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |